Related Experiment Video
Updated: Jun 17, 2026

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
Interferon-alpha2b induces p21cip1/waf1 degradation and cell proliferation in HeLa cells
Ken Ota1, Tomoh Matsumiya, Hirotake Sakuraba
1Department of Gastroenterology and Hematology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Abstract:
Type I interferons (IFNs) are a family of cytokines that exhibit various biological activities. Besides their roles in immune response, IFNs have been known to modulate cell proliferation and to induce apoptosis. Thus, IFNs are used as an antitumor agent against certain types of cancer, but it is unclear why many other cancers are not influenced by IFNs. Here, we found that IFN-alpha2b, a subfamily of IFN-alpha, enhanced proliferation of HeLa cells, a cell line derived from human cervical cancer. IFN-alpha2b was rather inhibitory on the growth of other types of cervical cancer cells including those positive for HPV. Among the proliferation- and the apoptosis-related genes, p21(cip1/waf1) (p21) was upregulated by IFN-alpha2b, whereas p53, p27 or BCL-2 associated X protein (BAX) was not affected. IFN-alpha2b did not alter promoter activities of p21 but did prolong the decay of p21 mRNA. In contrast, the level of p21 protein was lowered by IFN-alpha2b, and half-life analysis of p21 protein revealed that IFN-alpha2b enhances p21 protein instability in HeLa cells. Pretreatment of the cells with MG132, a proteasome inhibitor, abolished the IFN-alpha2b-mediated p21 degradation, suggesting that IFN-alpha2b accelerated the ubiquitin-proteasome dependent degradation of p21. Consistent with these results, IFN-alpha2b increased S-phase cell cycle distribution in HeLa cells. In addition, IFN-alpha2b liberated the cells from G(1)-phase arrest by 5-fluorouracil (5-FU) and from G(2)-phase arrest by paclitaxel. These results provide a novel role of Type I IFNs in cell cycle regulation and may define an importance of individualized IFN-based therapy against specific types of cancer.
Insights
Type I interferons (IFNs) can unexpectedly enhance cervical cancer cell proliferation by targeting p21 protein degradation. This finding suggests personalized IFN therapy may be crucial for effective cancer treatment.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Type I interferons (IFNs) are cytokines with diverse biological activities, including roles in immune response, cell proliferation, and apoptosis.
- IFNs are utilized as antitumor agents, yet their efficacy varies across different cancer types, with mechanisms remaining unclear.
- The specific impact of IFNs on cervical cancer cell lines and their underlying molecular pathways requires further investigation.
Purpose of the Study:
- To investigate the effect of IFN-alpha2b on the proliferation and apoptosis of human cervical cancer cells.
- To elucidate the molecular mechanisms by which IFN-alpha2b influences cell cycle regulation and gene expression.
- To explore the potential of IFN-alpha2b in overcoming drug-induced cell cycle arrest in cancer cells.
Main Methods:
- Treatment of HeLa and other cervical cancer cell lines with IFN-alpha2b.
- Analysis of proliferation and apoptosis-related gene expression (p21, p53, BAX).
- Assessment of p21 mRNA stability, protein degradation, and cell cycle distribution (S-phase).
- Investigation of IFN-alpha2b's effect on drug-induced cell cycle arrest (5-FU, paclitaxel) using proteasome inhibitor MG132.
Main Results:
- IFN-alpha2b enhanced proliferation in HeLa cervical cancer cells but inhibited other cervical cancer cell lines.
- IFN-alpha2b upregulated p21 mRNA but decreased p21 protein levels by accelerating its ubiquitin-proteasome dependent degradation.
- IFN-alpha2b treatment led to increased S-phase cell cycle distribution and released cells from G1 and G2 phase arrests induced by 5-FU and paclitaxel, respectively.
Conclusions:
- IFN-alpha2b exhibits differential effects on cervical cancer cell proliferation, enhancing it in HeLa cells.
- IFN-alpha2b modulates cell cycle progression through the destabilization of p21 protein via proteasomal degradation.
- These findings highlight a novel role for Type I IFNs in cell cycle regulation and underscore the importance of individualized IFN-based cancer therapies.
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
Inhibitors of Virion Maturation and Assembly